Lidds AB Sustainability Reports
LIDDS AB is a pharmaceutical company that develops drug products based on its proprietary and clinically tested NanoZolid drug delivery technology. The company specializes in the development of oncology drugs designed for local and controlled long-term release.
Sector: Manufacturing
Country: Sweden
Exchange: Nasdaq Stockholm
LEI: 549300YYW8B918K7UN72
FIGI: BBG006WXTK57
11 reports from 2014 to 2024
